Management of chronic kidney disease-mineral and bone disorder

Korean working group recommendations

Eunah Hwang, Bum Soon Choi, Kook Hwan Oh, Young-Joo Kwon, Gheun Ho Kim

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

For Korean dialysis patients, chronic kidney disease-mineral bone disorder is a serious burden because of cardiovascular calcification and mortality. However, recent epidemiologic data have demonstrated that many patients undergoing maintenance hemodialysis are out of the target ranges of serum calcium, phosphorus, and intact parathyroid hormone. Thus, we felt the necessity for the development of practical recommendations to treat abnormal serum phosphorus, calcium, and iPTH in dialysis patients. In this paper, we briefly comment on the measurement of serum calcium, phosphorus, iPTH, dialysate calcium concentration, dietary phosphorus restriction, use of phosphate binders, and medical and surgical options to correct secondary hyperparathyroidism. In particular, for the optimal management of secondary hyperparathyroidism, we suggest a simplified medication adjustment according to certain ranges of serum phosphorus and calcium. Large-scale, well-designed clinical studies are required to support our strategies to control chronic kidney disease-mineral bone disorder in this country. Based on such data, our practice guidelines could be established and better long-term outcomes should be anticipated in our dialysis patients.

Original languageEnglish
Pages (from-to)4-12
Number of pages9
JournalKidney Research and Clinical Practice
Volume34
Issue number1
DOIs
Publication statusPublished - 2015 Mar 1

Fingerprint

Chronic Kidney Disease-Mineral and Bone Disorder
Phosphorus
Calcium
Dialysis
Secondary Hyperparathyroidism
Serum
Dietary Phosphorus
Dialysis Solutions
Parathyroid Hormone
Practice Guidelines
Renal Dialysis
Phosphates
Maintenance
Mortality

Keywords

  • Calcium
  • Dialysis
  • Phosphorus
  • Secondary hyperparathyroidism

ASJC Scopus subject areas

  • Nephrology
  • Urology

Cite this

Management of chronic kidney disease-mineral and bone disorder : Korean working group recommendations. / Hwang, Eunah; Choi, Bum Soon; Oh, Kook Hwan; Kwon, Young-Joo; Kim, Gheun Ho.

In: Kidney Research and Clinical Practice, Vol. 34, No. 1, 01.03.2015, p. 4-12.

Research output: Contribution to journalArticle

Hwang, Eunah ; Choi, Bum Soon ; Oh, Kook Hwan ; Kwon, Young-Joo ; Kim, Gheun Ho. / Management of chronic kidney disease-mineral and bone disorder : Korean working group recommendations. In: Kidney Research and Clinical Practice. 2015 ; Vol. 34, No. 1. pp. 4-12.
@article{91a84f46a5714504bfe61935de9ef083,
title = "Management of chronic kidney disease-mineral and bone disorder: Korean working group recommendations",
abstract = "For Korean dialysis patients, chronic kidney disease-mineral bone disorder is a serious burden because of cardiovascular calcification and mortality. However, recent epidemiologic data have demonstrated that many patients undergoing maintenance hemodialysis are out of the target ranges of serum calcium, phosphorus, and intact parathyroid hormone. Thus, we felt the necessity for the development of practical recommendations to treat abnormal serum phosphorus, calcium, and iPTH in dialysis patients. In this paper, we briefly comment on the measurement of serum calcium, phosphorus, iPTH, dialysate calcium concentration, dietary phosphorus restriction, use of phosphate binders, and medical and surgical options to correct secondary hyperparathyroidism. In particular, for the optimal management of secondary hyperparathyroidism, we suggest a simplified medication adjustment according to certain ranges of serum phosphorus and calcium. Large-scale, well-designed clinical studies are required to support our strategies to control chronic kidney disease-mineral bone disorder in this country. Based on such data, our practice guidelines could be established and better long-term outcomes should be anticipated in our dialysis patients.",
keywords = "Calcium, Dialysis, Phosphorus, Secondary hyperparathyroidism",
author = "Eunah Hwang and Choi, {Bum Soon} and Oh, {Kook Hwan} and Young-Joo Kwon and Kim, {Gheun Ho}",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.krcp.2015.02.002",
language = "English",
volume = "34",
pages = "4--12",
journal = "Kidney Research and Clinical Practice",
issn = "2211-9132",
publisher = "Elsevier Korea",
number = "1",

}

TY - JOUR

T1 - Management of chronic kidney disease-mineral and bone disorder

T2 - Korean working group recommendations

AU - Hwang, Eunah

AU - Choi, Bum Soon

AU - Oh, Kook Hwan

AU - Kwon, Young-Joo

AU - Kim, Gheun Ho

PY - 2015/3/1

Y1 - 2015/3/1

N2 - For Korean dialysis patients, chronic kidney disease-mineral bone disorder is a serious burden because of cardiovascular calcification and mortality. However, recent epidemiologic data have demonstrated that many patients undergoing maintenance hemodialysis are out of the target ranges of serum calcium, phosphorus, and intact parathyroid hormone. Thus, we felt the necessity for the development of practical recommendations to treat abnormal serum phosphorus, calcium, and iPTH in dialysis patients. In this paper, we briefly comment on the measurement of serum calcium, phosphorus, iPTH, dialysate calcium concentration, dietary phosphorus restriction, use of phosphate binders, and medical and surgical options to correct secondary hyperparathyroidism. In particular, for the optimal management of secondary hyperparathyroidism, we suggest a simplified medication adjustment according to certain ranges of serum phosphorus and calcium. Large-scale, well-designed clinical studies are required to support our strategies to control chronic kidney disease-mineral bone disorder in this country. Based on such data, our practice guidelines could be established and better long-term outcomes should be anticipated in our dialysis patients.

AB - For Korean dialysis patients, chronic kidney disease-mineral bone disorder is a serious burden because of cardiovascular calcification and mortality. However, recent epidemiologic data have demonstrated that many patients undergoing maintenance hemodialysis are out of the target ranges of serum calcium, phosphorus, and intact parathyroid hormone. Thus, we felt the necessity for the development of practical recommendations to treat abnormal serum phosphorus, calcium, and iPTH in dialysis patients. In this paper, we briefly comment on the measurement of serum calcium, phosphorus, iPTH, dialysate calcium concentration, dietary phosphorus restriction, use of phosphate binders, and medical and surgical options to correct secondary hyperparathyroidism. In particular, for the optimal management of secondary hyperparathyroidism, we suggest a simplified medication adjustment according to certain ranges of serum phosphorus and calcium. Large-scale, well-designed clinical studies are required to support our strategies to control chronic kidney disease-mineral bone disorder in this country. Based on such data, our practice guidelines could be established and better long-term outcomes should be anticipated in our dialysis patients.

KW - Calcium

KW - Dialysis

KW - Phosphorus

KW - Secondary hyperparathyroidism

UR - http://www.scopus.com/inward/record.url?scp=84926197076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926197076&partnerID=8YFLogxK

U2 - 10.1016/j.krcp.2015.02.002

DO - 10.1016/j.krcp.2015.02.002

M3 - Article

VL - 34

SP - 4

EP - 12

JO - Kidney Research and Clinical Practice

JF - Kidney Research and Clinical Practice

SN - 2211-9132

IS - 1

ER -